Beijing Okeanos Technology
Specialty biochemical reagents for life sciences research
About Beijing Okeanos Technology
Founded in 2006, Beijing Okeanos Technology Co., Ltd. is a high-tech enterprise focused on the life sciences sector. The firm develops and produces special chemical and biological reagents, as well as pharmaceutical intermediates. Its primary offerings include modified and unnatural amino acids, nucleoside derivatives, heterocyclic compounds, and fluorescent labeling reagents, which are crucial for sequencing and synthetic biology.
The company operates on a business-to-business model, providing custom synthesis and manufacturing services. Its client base includes major international pharmaceutical and chemical companies such as Pfizer, Novartis, P&G, and Dow. Revenue is generated through the sale of its chemical compounds and intermediates, as well as custom synthesis projects. The technical team is composed of talent from Peking University, Tsinghua University, and the Chinese Academy of Sciences, supported by an expert advisory board. This has enabled the company to secure over 80 patents.
Beijing Okeanos Technology has established a significant research and development footprint, with over 1,000 square meters of laboratory space. The company has also engaged in long-term scientific collaborations with renowned institutions, including Harvard University and Stanford University, to remain at the forefront of biochemical research. The company has successfully completed several funding rounds, including a Series B+ in December 2022. Its investors include Qiming Venture Partners, Gopher Asset Management, and CMB International Capital.
Source: Dealroom company dataNews
Open roles
Beijing Okeanos Technology in its local ecosystem
The Beijing Okeanos Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
- CGChina Baoan Group
CICC
BioTrack Capital
KingMed Diagnostics
Kunlun Capital
Qiming Venture Partners
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Beijing Okeanos Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Beijing Okeanos Technology on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.